Phio Pharmaceuticals Corp.Phio Pharmaceuticals Corp.Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.51 M‬USD
−3.5900USD
‪−10.83 M‬USD
‪4.55 M‬
Beta (1Y)
0.23

About Phio Pharmaceuticals Corp.

CEO
Robert J. Bitterman
Headquarters
Marlborough
Employees (FY)
9
Founded
2011
FIGI
BBG0024FKD97
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PHIO is 0.7650 USD — it has decreased by 0.36% in the past 24 hours. Watch Phio Pharmaceuticals Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Phio Pharmaceuticals Corp. stocks are traded under the ticker PHIO.
PHIO stock has fallen by 6.71% compared to the previous week, the month change is a 8.01% rise, over the last year Phio Pharmaceuticals Corp. has showed a 79.97% decrease.
We've gathered analysts' opinions on Phio Pharmaceuticals Corp. future price: according to them, PHIO price has a max estimate of 4.00 USD and a min estimate of 4.00 USD. Watch PHIO chart and read a more detailed Phio Pharmaceuticals Corp. stock forecast: see what analysts think of Phio Pharmaceuticals Corp. and suggest that you do with its stocks.
PHIO reached its all-time high on Mar 14, 2013 with the price of 708840.0000 USD, and its all-time low was 0.5000 USD and was reached on Jan 26, 2024. View more price dynamics on PHIO chart.
See other stocks reaching their highest and lowest prices.
PHIO stock is 4.63% volatile and has beta coefficient of 0.23. Track Phio Pharmaceuticals Corp. stock price on the chart and check out the list of the most volatile stocks — is Phio Pharmaceuticals Corp. there?
Today Phio Pharmaceuticals Corp. has the market capitalization of ‪3.51 M‬, it has increased by 21.44% over the last week.
Yes, you can track Phio Pharmaceuticals Corp. financials in yearly and quarterly reports right on TradingView.
Phio Pharmaceuticals Corp. is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
PHIO net income for the last quarter is ‪−2.15 M‬ USD, while the quarter before that showed ‪−1.90 M‬ USD of net income which accounts for −13.67% change. Track more Phio Pharmaceuticals Corp. financial stats to get the full picture.
No, PHIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 25, 2024, the company has 9.00 employees. See our rating of the largest employees — is Phio Pharmaceuticals Corp. on this list?
Like other stocks, PHIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Phio Pharmaceuticals Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Phio Pharmaceuticals Corp. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Phio Pharmaceuticals Corp. stock shows the sell signal. See more of Phio Pharmaceuticals Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.